BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25265848)

  • 1. Synthesis and antimicrobial activities of oxazepine and oxazocine derivatives.
    Tang J; Jiang YL; Wang BX; Shen YM
    Z Naturforsch C J Biosci; 2014; 69(7-8):283-90. PubMed ID: 25265848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and Characterization of Tetrachloro-1,3-Oxazepine Derivatives and Evaluation of their Biological Activities.
    Kshash AH
    Acta Chim Slov; 2020 Mar; 67(1):113-118. PubMed ID: 33558920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New derivatives of 7- and 8-member perhydrocyclic compounds. II. Studies on the effect on the central nervous system and circulatory system of new derivatives of perhydro-1,4-oxazepine, perhydro-1,4-diazepine, perhydro-1,4,5-oxadiazepine and perhydro-1,5-oxazocine containing the 2-guanidinoethyl group].
    Szadowska A; Działek S; Kiełek MB; Kusowska J; Wejman I
    Acta Pol Pharm; 1985; 42(1):55-60. PubMed ID: 4040312
    [No Abstract]   [Full Text] [Related]  

  • 4. [Synthesis of new 7, 8 and 9-membered heterocyclic compounds containing oxygen and nitrogen as heteroatoms. III. Synthesis of new hexahydro-1,5-oxazocine derivatives with potential pharmacological activity].
    Glinka R; Kotelko B
    Acta Pol Pharm; 1976; 33(1):39-48. PubMed ID: 1266642
    [No Abstract]   [Full Text] [Related]  

  • 5. [Heterocyclic amine derivatives - analogs of mebanazine, pheniprazine and phenelzine. II. Studies on the effect, on the central nervous system, of derivatives of perhydroazepine, perhydro-1,4-diazepine, perhydro-1,4-oxazepine, perhydro-1,5-oxazocine and morpholine-containing arylalkyloamine groups].
    Szadowska A; Mazur M; Szmigielski A; Szmigielska H; Winer A
    Acta Pol Pharm; 1983; 40(1):111-8. PubMed ID: 6136156
    [No Abstract]   [Full Text] [Related]  

  • 6. Sordarin oxazepine derivatives as potent antifungal agents.
    Serrano-Wu MH; St Laurent DR; Chen Y; Huang S; Lam KR; Matson JA; Mazzucco CE; Stickle TM; Tully TP; Wong HS; Vyas DM; Balasubramanian BN
    Bioorg Med Chem Lett; 2002 Oct; 12(19):2757-60. PubMed ID: 12217370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facile synthesis of tetracyclic azepine and oxazocine derivatives and their potential as MAPKAP-K2 (MK2) inhibitors.
    Rao AU; Xiao D; Huang X; Zhou W; Fossetta J; Lundell D; Tian F; Trivedi P; Aslanian R; Palani A
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1068-72. PubMed ID: 22182499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of dibenz[b,f][1,5]oxazocine derivatives for agonist activity at κ-opioid receptor.
    Mitra S; Banerjee TS; Hota SK; Bhattacharya D; Das S; Chattopadhyay P
    Eur J Med Chem; 2011 May; 46(5):1713-20. PubMed ID: 21392859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6,7-Dihydrobenzo[f]benzo[4,5]imidazo[1,2-d][1,4]oxazepine derivatives as selective inhibitors of PI3Kα.
    Yin Y; Zhang YQ; Jin B; Sha S; Wu X; Sangani CB; Wang SF; Qiao F; Lu AM; Lv PC; Zhu HL
    Bioorg Med Chem; 2015 Mar; 23(6):1231-40. PubMed ID: 25693787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naphthoxazepine inhibitors of HIV-1 integrase: synthesis and biological evaluation.
    Garofalo A; Grande F; Brizzi A; Aiello F; Dayam R; Neamati N
    ChemMedChem; 2008 Jun; 3(6):986-90. PubMed ID: 18383063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-substituted-4-aryl-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,5]oxazocin-5-one as a structurally new NK1 antagonist.
    Seto S; Tanioka A; Ikeda M; Izawa S
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1485-8. PubMed ID: 15713412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigations of anthelminthic activity and synthesis of new derivatives of perhydroazepine, perhydro-1,4-diazepine, perhydro-1,4-oxazepine and perhydro-1,5-oxazocine.
    Glinka R; Grzywacz M; Kotełko B; Majchrzak M; Malinowski H; Mikołajewska H; Mikiciukolasik E; Szkukliński J
    Pol J Pharmacol Pharm; 1980; 32(5):773-7. PubMed ID: 7196575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Synthesis of derivatives of perhydroazepine, perhydro-1,5-oxazocine, morpholine and piperazine containing 3-(isopropylamino)-propan-2-ol group--compounds with potential effect on the circulatory system and central nervous system].
    Kotełko B; Mikołajewska H; Glinka R; Guryn R
    Acta Pol Pharm; 1985; 42(5):433-6. PubMed ID: 3834763
    [No Abstract]   [Full Text] [Related]  

  • 14. Amino acid based enantiomerically pure 3-substituted benzofused heterocycles: A new class of antithrombotic agents.
    Mishra JK; Samanta K; Jain M; Dikshit M; Panda G
    Bioorg Med Chem Lett; 2010 Jan; 20(1):244-7. PubMed ID: 19932967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial Activity and Structure-Activity Relationship of a Series of Newly Synthesized Pleuromutilin Derivatives.
    Li YG; Wang JX; Zhang GN; Zhu M; You XF; Hu XX; Zhang F; Wang YC
    Chem Biodivers; 2019 Feb; 16(2):e1800560. PubMed ID: 30467968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyrimido-oxazepine as a versatile template for the development of inhibitors of specific kinases.
    Pan W; Liu H; Xu YJ; Chen X; Kim KH; Milligan DL; Columbus J; Hadari YR; Kussie P; Wong WC; Labelle M
    Bioorg Med Chem Lett; 2005 Dec; 15(24):5474-7. PubMed ID: 16198560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and anticonvulsant evaluation of 6-amino-1,4-oxazepane-3,5-dione derivatives.
    Sharma G; Park JY; Park MS
    Arch Pharm Res; 2008 Jul; 31(7):838-42. PubMed ID: 18704324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of 10-alkoxy-5, 6-dihydro-triazolo[4,3-d]benzo[f][1,4]oxazepine derivatives with anticonvulsant activity.
    Deng XQ; Wei CX; Li FN; Sun ZG; Quan ZS
    Eur J Med Chem; 2010 Jul; 45(7):3080-6. PubMed ID: 20416982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naphtho[2,1-b][1,5] and [1,2-f][1,4]oxazocines as selective NK1 antagonists.
    Ohnmacht CJ; Albert JS; Bernstein PR; Rumsey WL; Masek BB; Dembofsky BT; Koether GM; Andisik DW; Aharony D
    Bioorg Med Chem; 2004 May; 12(10):2653-69. PubMed ID: 15110847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of crucial structural requirements of 2-substituted pyrimido[4,5-b][1,5]oxazocines as NK(1) receptor antagonist by axially chiral derivatives.
    Seto S; Asano J
    Bioorg Med Chem; 2007 Aug; 15(15):5083-9. PubMed ID: 17540575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.